Docetaxel plus S-1 versus cisplatin plus S-1 in unresectable gastric cancer without measurable lesions: a randomized phase II trial (HERBIS-3)
暂无分享,去创建一个
D. Sakai | T. Satoh | Y. Kurokawa | T. Shimokawa | R. Kawabata | K. Fujitani | Y. Kimura | H. Kawakami | J. Matsuyama | K. Nishikawa | A. Takeno | T. Terazawa | Y. Makari